Proliferative diabetic retinopathy (PDR) is the fourth and most advanced stage of diabetic retinopathy, defined by the growth of abnormal new blood vessels on the retinal surface and into the vitreous gel. These fragile vessels bleed without warning. When scar tissue forms along them and contracts, it can pull the retina away from the wall of the eye, causing severe or permanent vision loss. Routine retinal imaging detects the disease at every stage, often before a person notices any change in vision, which is why regular exams matter as soon as a diabetes diagnosis is made.
What Is Proliferative Diabetic Retinopathy?
PDR is defined by neovascularization: the retina, deprived of oxygen, generates new blood vessels that grow along its surface and into the vitreous. A 2025 review published in Cells confirmed that diabetic retinopathy affects nearly one-third of all patients with diabetes mellitus and remains a leading cause of blindness worldwide. These newly formed vessels are structurally weak, prone to sudden hemorrhage, and capable of pulling the retina from its attachment point.
OPTYX optometrists detect and monitor diabetic retinopathy at all four stages. When imaging reveals PDR or high-risk neovascular features, OPTYX coordinates a timely referral to a retina specialist.
What Is the Difference Between Proliferative and Non-Proliferative DR?
Non-proliferative DR (NPDR) is the earlier phase where existing retinal vessels leak or balloon, but no new vessels have formed; PDR begins the moment neovascularization occurs.
| Feature | Non-Proliferative DR (NPDR) | Proliferative DR (PDR) |
|---|---|---|
| New blood vessel growth | No | Yes |
| Microaneurysms present | Yes | Yes |
| Vitreous hemorrhage risk | Low | High |
| Specialist procedures typically needed | Rarely | Yes |
| Early symptoms | Often none | Often none; sudden changes later |
Both stages can destroy vision without producing early warning signs. The transition from nonproliferative to proliferative diabetic retinopathy is the clinical turning point that drives major treatment decisions, which is why the difference between proliferative vs nonproliferative diabetic retinopathy matters far beyond labeling.
The Four Stages of Diabetic Retinopathy
Diabetic retinopathy progresses through four recognized clinical stages. Each stage changes what the retina looks like on imaging, how often it needs monitoring, and when specialist referral becomes necessary.
Mild Nonproliferative Diabetic Retinopathy
Mild NPDR is the earliest recognizable stage. Microaneurysms, tiny balloon-like bulges in retinal capillary walls, begin to form. These are invisible to the patient and detectable only on retinal imaging. Tight glycemic control and annual monitoring are the standard response; eye-specific procedures are rarely needed at this stage.
Moderate Nonproliferative Diabetic Retinopathy
In moderate NPDR, vessel damage spreads. Dot-and-blot hemorrhages, hard exudates, and cotton-wool spots appear on the fundus as blood flow to portions of the retina becomes compromised. Blood pressure control becomes as important as blood sugar management at this point. Monitoring frequency shortens to every six months in most cases.
Severe Nonproliferative Diabetic Retinopathy
Severe nonproliferative diabetic retinopathy marks the threshold before proliferative change. The retina is significantly oxygen-deprived, triggering a surge in vascular endothelial growth factor (VEGF). This VEGF-driven mechanism drives progression from severe NPDR into PDR. Without intervention, a substantial proportion of patients with severe NPDR cross into proliferative disease within one year.
Proliferative Diabetic Retinopathy
This stage begins when new, fragile vessels emerge from the retinal surface and grow into the vitreous, spanning a range from early PDR to high-risk PDR. Two clinical findings define this stage: neovascularization of the disc (NVD), where new vessels grow at or near the optic nerve head, and neovascularization elsewhere (NVE), where vessels arise from other retinal regions. These vessels rupture easily. They bleed without warning.
What Is Neovascularization, and Why Does It Threaten Vision?
Neovascularization is the growth of structurally abnormal new blood vessels that the retina generates when chronic high blood sugar deprives it of oxygen. The retina releases VEGF as a distress signal, which triggers vessel formation as a survival response. These vessels cause more harm than the oxygen shortage they were meant to solve: they leak blood into the vitreous, generate fibrous scar tissue, and contract to pull the retina from the wall of the eye. Proliferative diabetic retinopathy neovascularization is the defining mechanism behind vision loss in advanced diabetic eye disease.
Symptoms of Proliferative Diabetic Retinopathy
Early PDR is frequently symptom-free. Symptoms appear as the new vessels bleed or as complications develop:
- Floaters or dark spots: small bleeds from fragile new vessels cause particles to drift across the visual field.
- Dark streaks: larger bleeds create streak-like shadows that obscure parts of vision.
- Blurred or fluctuating vision: fluid or blood near the macula distorts central focus.
- A shadow or curtain across the visual field: signals possible retinal detachment or significant hemorrhage.
- Sudden severe vision loss: occurs when a large bleed fills the vitreous or the retina detaches.
Who Is Most at Risk for PDR?
Diabetes duration is the strongest single predictor of PDR. The condition is rare in the first decade of either Type 1 or Type 2 diabetes and becomes progressively more common after 20 years. These additional factors also raise the risk:
- Poor HbA1c control: sustained high blood sugar accelerates retinal vessel damage more than any other modifiable variable.
- Hypertension: elevated blood pressure compounds stress on already-fragile retinal capillaries.
- Diabetic nephropathy: kidney disease is a marker of systemic microvascular damage that tracks closely with retinal disease progression.
- Hyperlipidemia: elevated lipids contribute to hard exudate formation and worsening retinal ischemia.
- Pregnancy with pre-existing diabetes: hormonal shifts can accelerate DR progression rapidly and require closer retinal monitoring throughout gestation.
- Smoking: impairs oxygenation and worsens vascular compromise throughout the retina.
Any person with diabetes, regardless of current vision clarity, should have annual retinal imaging.
Complications: Macular Edema, Vitreous Hemorrhage, and Retinal Detachment
The abnormal vessels that define PDR drive three sight-threatening complications. Managing these complications is a central goal in PDR treatment.
- Diabetic macular edema: fluid leaks from damaged vessels into the macula, distorting central vision. This complication can develop at any stage of diabetic retinopathy, including earlier non-proliferative stages; it has its own ICD-10 coding distinction and influences treatment decisions independently of PDR stage. Proliferative diabetic retinopathy with macular edema requires the most intensive management.
- Vitreous hemorrhage: fragile new vessels rupture and bleed into the vitreous gel, causing sudden floaters, dark spots, or complete vision blackout.
- Traction retinal detachment: fibrous scar tissue forms along new vessels, then contracts and physically pulls the retina away from the underlying pigment epithelium.
How Is PDR Diagnosed? What Happens at Your Eye Exam
Diagnosis of PDR begins with comprehensive retinal imaging. At OPTYX, the primary imaging tool is Optos ultra-widefield retinal imaging, which captures up to 200 degrees of the retina in a single scan and in most cases does not require dilation. Standard dilated fundus exams cover a narrower field and can miss peripheral changes that wide-field imaging detects at an earlier stage.
What to expect at a retinal exam for diabetic retinopathy at OPTYX:
- Optos ultra-widefield scan: captures the full retina, including the periphery where early PDR changes often begin.
- Visual acuity measurement: establishes a baseline and flags reductions linked to macular involvement.
- Intraocular pressure check: elevated pressure can accompany neovascular changes in advanced cases.
- Dilation if indicated: required for specific findings that need closer central fundus detail.
- Review of findings: the OPTYX optometrist explains what the images show and what stage applies.
- Referral coordination: when PDR or high-risk features are present, a referral to a retina specialist is arranged directly from the exam visit.
Treatment Options for PDR
Treatment for PDR is performed by retina specialists. OPTYX optometrists detect and monitor DR and coordinate referrals; the procedures described here are outside optometric scope and are provided to help patients understand what a specialist may recommend.
Three main approaches exist depending on PDR severity and the presence of complications:
- Panretinal photocoagulation (PRP) laser: applies laser burns to the peripheral ischemic retina, reducing the VEGF signal that drives neovascularization and causing new vessels to regress.
- Anti-VEGF injections (bevacizumab, ranibizumab, aflibercept): block the VEGF protein directly at its source. A 2025 meta-analysis in Ophthalmology Retina found that anti-VEGF treatment produced better best-corrected visual acuity outcomes than PRP at both 3 and 12 months, with combination therapy also outperforming PRP for visual acuity at 12 months.
- Vitrectomy: surgical removal of vitreous blood and fibrous scar tissue when hemorrhage or retinal detachment cannot resolve on its own.
A 2023 meta-analysis in Eye found that aflibercept significantly reduced progression to vision-threatening complications in NPDR eyes without centre-involving diabetic macular oedema compared with observation over two years. Systemic management of blood sugar and blood pressure remains essential at every stage of DR.
If you have diabetes, scheduling a retinal imaging exam is the most reliable way to catch changes before symptoms appear. Ask about Optos ultra-widefield retinal imaging when you call.
When Is Proliferative Diabetic Retinopathy a Medical Emergency?
A sudden shower of new floaters, a dark curtain across any part of your visual field, or a sudden drop in vision require same-day evaluation or emergency care, not a routine appointment. These signs may indicate a vitreous hemorrhage or traction retinal detachment, both of which can progress to permanent vision loss within hours to days.
Emergency warning signs that require immediate action:
- Sudden new floaters or a shower of dark spots: may signal a hemorrhage from a ruptured new vessel.
- A shadow, curtain, or veil in the visual field: indicates possible retinal detachment requiring urgent surgical evaluation.
- Sudden blurred or lost vision: requires ruling out hemorrhage or detachment urgently, before the next business day.
- Flashes of light: can indicate traction on the retina from fibrous scar tissue pulling against its surface.
- Sudden eye pain alongside a vision change: warrants same-day emergency evaluation without waiting to schedule.
If you have been diagnosed with PDR and experience any of these signs, contact your retina specialist immediately or go to an emergency room.
ICD-10 Codes for PDR
Patients diagnosed with PDR will see ICD-10 codes on visit summaries, insurance explanations of benefits, and referral paperwork. Knowing what these codes mean removes confusion at the billing stage.
Main ICD-10-CM codes for Type 2 diabetes with PDR:
- E11.351: Type 2 DM with PDR with macular edema, right eye.
- E11.352: Type 2 DM with PDR with macular edema, left eye.
- E11.353: Type 2 DM with PDR with macular edema, bilateral.
- E11.359: Type 2 DM with PDR with macular edema, unspecified eye.
- E11.3411: Type 2 DM with PDR without macular edema, right eye.
- E11.3412: Type 2 DM with PDR without macular edema, left eye.
- E11.3413: Type 2 DM with PDR without macular edema, bilateral.
Type 1 diabetes with PDR uses the E10.35x series, following the same laterality and macular edema distinctions. The PDR ICD-10 code on a patient's paperwork reflects both the diabetes type and whether macular edema is present alongside neovascularization. Non-proliferative diabetic retinopathy ICD-10 codes fall in the E11.32x (mild NPDR), E11.33x (moderate NPDR), and E11.34x (severe NPDR) series for Type 2 diabetes. Coding specifics are confirmed by the treating provider; patients can ask for the specific code on their visit summary to verify insurance coverage.
Book Your Retinal Exam at OPTYX
At OPTYX, optometrists use Optos ultra-widefield imaging to screen for diabetic retinopathy at all four stages, often without dilation, and detect changes early enough to allow timely specialist referral. Whether you have been diagnosed with any stage of DR or have diabetes and have not had a retinal imaging exam this year, an appointment is the most direct way to know where you stand. Book an Eye Exam at OPTYX. Framing New Yorkers Since 1971, OPTYX sees patients across Manhattan, Long Island, the North Fork, the Hamptons, and Westchester.
Sources
- Macaron MM et al. (2025). Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Ophthalmology Retina. PubMed
- Chaudhary V et al. (2023). Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. Eye (London, England). PubMed
- Seo H et al. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells. PubMed
